Want to see IN:FISCHER full AI Analyst Report?
FISCHER Stock Chart & Stats
₹43.67
--
Market closed
₹43.67
--
Day’s Range― - ―
52-Week Range₹31.13 - ₹124.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)267.56K
Market Cap
₹25.26B
Enterprise Value₹72.00K
Total Cash (Recent Filing)₹250.46M
Total Debt (Recent Filing)₹1.07B
Price to Earnings (P/E)95.7
Beta0.31
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.01%
Share Statistics
EPS (TTM)0.40
Shares Outstanding648,515,440
10 Day Avg. Volume611,655
30 Day Avg. Volume267,556
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)6.83
Price to Sales (P/S)8.52
P/FCF Ratio-20.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
FY2026 Revenue & Margin ExpansionThe step-change to sizable revenue (3.09B) and materially higher margins demonstrates the business can achieve profitable scale. Durable margin expansion suggests improved operating leverage and a stronger core business model that, if sustained, supports long-term cash generation and reinvestment.
Improved Balance Sheet PositionManageable leverage and growing equity provide a clearer capital cushion versus prior years. This improved solvency profile reduces near-term refinancing stress, supports continued investment in R&D or capacity, and gives the company flexibility to pursue strategic initiatives over the medium term.
High Operational ScalabilityVery high revenue per employee implies a scalable, asset-light operating model with potential for margin durability. A lean headcount relative to sales suggests the company can scale revenues without proportional increases in SG&A, supporting sustained profitability if growth persists.
Bears Say
Severe Cash BurnDeep, recurring negative operating and free cash flow indicates the business is not converting accounting profits into cash. Continued cash burn increases dependence on external financing, heightens dilution or interest burden risk, and threatens long-term sustainability if cash generation does not improve.
Material Debt Increase Vs FY2024A large jump in nominal debt and a history of negative equity signal prior capital strain and higher credit vulnerability. Elevated leverage compared with recent history raises refinancing and interest-service risk, which could constrain strategic options if cash flows remain weak.
Profitability Volatility / Track Record RiskRecent FY2026 profitability follows periods of losses and zero revenue, indicating earnings are not yet proven durable. Such volatility complicates forecasting, increases execution risk for sustaining margins, and means investors must see repeatable outcomes before treating current results as the new baseline.
Fischer Medical Ventures Ltd News
FISCHER FAQ
What was Fischer Medical Ventures Ltd’s price range in the past 12 months?
Fischer Medical Ventures Ltd lowest stock price was ₹31.13 and its highest was ₹124.20 in the past 12 months.
What is Fischer Medical Ventures Ltd’s market cap?
Fischer Medical Ventures Ltd’s market cap is ₹25.26B.
When is Fischer Medical Ventures Ltd’s upcoming earnings report date?
Fischer Medical Ventures Ltd’s upcoming earnings report date is Aug 06, 2026 which is today.
How were Fischer Medical Ventures Ltd’s earnings last quarter?
Currently, no data Available
Is Fischer Medical Ventures Ltd overvalued?
According to Wall Street analysts Fischer Medical Ventures Ltd’s price is currently Overvalued.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd pays a Notavailable dividend of ₹0.005 which represents an annual dividend yield of 0.01%. See more information on Fischer Medical Ventures Ltd dividends here
What is Fischer Medical Ventures Ltd’s EPS estimate?
Fischer Medical Ventures Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fischer Medical Ventures Ltd have?
Fischer Medical Ventures Ltd has 648,515,440 shares outstanding.
What happened to Fischer Medical Ventures Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Fischer Medical Ventures Ltd?
Currently, no hedge funds are holding shares in IN:FISCHER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Technical Analysis
Aarti Pharmalabs Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Thyrocare Technologies Ltd
―